Search Login Register

Aztreonam Summary

Description: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.

Also Known As: Az-threonam; Azactam; Azthreonam; Bristol-Myers Squibb Brand of Aztreonam; Esteve Brand of Aztreonam Show All >>

Networked: 595 relevant articles (107 outcomes, 134 trials/studies) for this Drug

Key Diseases for which Aztreonam is Relevant

  1. Infection : 44 outcomes 62 studies in 259 results
  2. Urinary Tract Infections (Urinary Tract Infection) : 12 outcomes 11 studies in 58 results
  3. Cystic Fibrosis (Mucoviscidosis) : 8 outcomes 14 studies in 60 results
  4. Respiratory Tract Infections (Respiratory Tract Infection) : 6 outcomes 5 studies in 23 results
  5. Pneumonia (Pneumonitis) : 5 outcomes 7 studies in 32 results
Show All >>

Drugs Related to Aztreonam

  1. Gentamicins (Gentamicin)
  2. Vancomycin
  3. Ceftazidime (Fortum)
  4. Anti-Bacterial Agents (Antibiotics)
  5. Clindamycin (Cleocin)
  6. Piperacillin
  7. Penicillins (Penicillin)
  8. Ampicillin (Omnipen)
  9. Norfloxacin
  10. tigecycline (Tygacil)
Show All >>

Therapies Related to Aztreonam

  1. Drug Therapy (Chemotherapy)
  2. Continuous Ambulatory Peritoneal Dialysis (CAPD)
  3. Aftercare (After-Treatment)
  4. Intramuscular Injections
  5. Renal Dialysis (Hemodialysis)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.